Home > Insider Trading > Filing (0001192482-14-000229)

Filing Details

Accession Number:: 0001192482-14-000229
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-12 12:39:31
Reporting Period:: 2014-11-10

Filing Date:: 2014-11-12
Accepted Time:: 2014-11-12 12:39:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1361248	Tetralogic Pharmaceuticals Corp	TLOG	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1390406	J Paul Schmitt	C/O Novitas Capital Iii, L.p. 116 Research Drive Bethlehem PA 18015		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-10	10,000	$4.06	10,000	No	4	P	Direct
Common Stock	Acquisiton	2014-11-10	10,000	$4.14	10,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,512,962	Indirect	See footnote

Footnotes

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.01 to $4.0968, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The securities are held of record by Novitas Capital III, LP. ("Novitas III"), Novitas Capital III GP, LP ("Novitas GP") and Novitas Capital III GP Manager, LLC ("Novitas Manager"). Novitas GP is the general partner of Novitas III and Novitas Manager is the general partner of Novitas GP. The reporting person, a partner in HVPIII and HVAIII, has voting and investment power over the shares beneficially owned by HVPIII and HVAIII, and disclaims beneficial ownership of the shares beneficially owned by Novitas III, Novitas GP and Novitas Manager, except to the extent of his pecuniary interest therein.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.0488 to $4.2673, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The securities are held of record by the reporting person's spouse, Sharon Z. Schmitt. The reporting person does not have voting and investment power over the shares beneficially owend by Sharon Z. Schmitt, and disclaims beneficial ownership of the shares beneficially owned by Sharon Z. Schmitt.